Cargando…
Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial
BACKGROUND: Chronic pulmonary infection with Pseudomonas aeruginosa is one of the most important causes of mortality and morbidity in cystic fibrosis. If antibiotics are commenced promptly, infection can be eradicated. The aim of the trial was to compare the effectiveness and safety of intravenous c...
Autores principales: | Hewer, Simon C Langton, Smyth, Alan R, Brown, Michaela, Jones, Ashley P, Hickey, Helen, Kenna, Dervla, Ashby, Deborah, Thompson, Alexander, Williamson, Paula R |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606906/ https://www.ncbi.nlm.nih.gov/pubmed/33007285 http://dx.doi.org/10.1016/S2213-2600(20)30331-3 |
Ejemplares similares
-
Feasibility study to inform the design of a randomised controlled trial to eradicate Pseudomonas aeruginosa infection in individuals with Cystic Fibrosis
por: Hickey, Helen R, et al.
Publicado: (2010) -
Eradication of Pseudomonas aeruginosa in adults with cystic fibrosis
por: Kenny, S L, et al.
Publicado: (2014) -
The role of Psl in the failure to eradicate Pseudomonas aeruginosa biofilms in children with cystic fibrosis
por: Morris, Amanda J., et al.
Publicado: (2021) -
No benefit of longer eradication therapy of Pseudomonas aeruginosa primoinfections in pediatric cystic fibrosis
por: Claude, F., et al.
Publicado: (2019) -
Eradication of Pseudomonas aeruginosa with inhaled
colistin in adults with non-cystic fibrosis bronchiectasis
por: Blanco-Aparicio, Marina, et al.
Publicado: (2019)